vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and FIRST ADVANTAGE CORP (FA). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $420.0M, roughly 1.2× FIRST ADVANTAGE CORP). FIRST ADVANTAGE CORP runs the higher net margin — 0.8% vs -10.1%, a 10.9% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 36.8%). FIRST ADVANTAGE CORP produced more free cash flow last quarter ($62.2M vs $-69.0M). Over the past eight quarters, FIRST ADVANTAGE CORP's revenue compounded faster (57.5% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

First Advantage Corp is a leading global provider of end-to-end workforce screening and background verification solutions. It serves clients across diverse sectors including technology, healthcare, finance, retail, and manufacturing, ranging from small businesses to large multinational enterprises, helping reduce hiring risks, meet regulatory requirements, and build secure, trusted work environments globally.

CLOV vs FA — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.2× larger
CLOV
$487.7M
$420.0M
FA
Growing faster (revenue YoY)
CLOV
CLOV
+8.0% gap
CLOV
44.7%
36.8%
FA
Higher net margin
FA
FA
10.9% more per $
FA
0.8%
-10.1%
CLOV
More free cash flow
FA
FA
$131.1M more FCF
FA
$62.2M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
FA
FA
Annualised
FA
57.5%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
FA
FA
Revenue
$487.7M
$420.0M
Net Profit
$-49.3M
$3.5M
Gross Margin
Operating Margin
-10.1%
10.7%
Net Margin
-10.1%
0.8%
Revenue YoY
44.7%
36.8%
Net Profit YoY
-123.2%
103.5%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
FA
FA
Q4 25
$487.7M
$420.0M
Q3 25
$496.6M
$409.2M
Q2 25
$477.6M
$390.6M
Q1 25
$462.3M
$354.6M
Q4 24
$337.0M
$307.1M
Q3 24
$331.0M
$199.1M
Q2 24
$356.3M
$184.5M
Q1 24
$346.9M
$169.4M
Net Profit
CLOV
CLOV
FA
FA
Q4 25
$-49.3M
$3.5M
Q3 25
$-24.4M
$2.6M
Q2 25
$-10.6M
$308.0K
Q1 25
$-1.3M
$-41.2M
Q4 24
$-22.1M
$-100.4M
Q3 24
$-9.2M
$-8.9M
Q2 24
$7.4M
$1.9M
Q1 24
$-19.2M
$-2.9M
Gross Margin
CLOV
CLOV
FA
FA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
FA
FA
Q4 25
-10.1%
10.7%
Q3 25
-4.9%
10.3%
Q2 25
-2.2%
9.7%
Q1 25
-0.3%
2.1%
Q4 24
-6.4%
-26.3%
Q3 24
-2.7%
4.6%
Q2 24
2.0%
5.4%
Q1 24
-6.5%
-0.4%
Net Margin
CLOV
CLOV
FA
FA
Q4 25
-10.1%
0.8%
Q3 25
-4.9%
0.6%
Q2 25
-2.2%
0.1%
Q1 25
-0.3%
-11.6%
Q4 24
-6.6%
-32.7%
Q3 24
-2.8%
-4.4%
Q2 24
2.1%
1.0%
Q1 24
-5.5%
-1.7%
EPS (diluted)
CLOV
CLOV
FA
FA
Q4 25
$0.03
Q3 25
$0.01
Q2 25
$0.00
Q1 25
$-0.24
Q4 24
$-0.67
Q3 24
$-0.06
Q2 24
$0.01
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
FA
FA
Cash + ST InvestmentsLiquidity on hand
$78.3M
$240.0M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$308.7M
$1.3B
Total Assets
$541.0M
$3.8B
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
FA
FA
Q4 25
$78.3M
$240.0M
Q3 25
$216.8M
Q2 25
$184.3M
Q1 25
$172.0M
Q4 24
$194.5M
$168.7M
Q3 24
$288.0M
$307.4M
Q2 24
$254.8M
$269.6M
Q1 24
$208.3M
$246.0M
Total Debt
CLOV
CLOV
FA
FA
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
FA
FA
Q4 25
$308.7M
$1.3B
Q3 25
$340.9M
$1.3B
Q2 25
$344.2M
$1.3B
Q1 25
$336.1M
$1.3B
Q4 24
$341.1M
$1.3B
Q3 24
$342.2M
$920.7M
Q2 24
$324.9M
$913.3M
Q1 24
$292.5M
$907.7M
Total Assets
CLOV
CLOV
FA
FA
Q4 25
$541.0M
$3.8B
Q3 25
$559.7M
$3.9B
Q2 25
$575.0M
$3.9B
Q1 25
$583.7M
$3.9B
Q4 24
$580.7M
$3.9B
Q3 24
$653.0M
$1.7B
Q2 24
$674.2M
$1.6B
Q1 24
$671.8M
$1.6B
Debt / Equity
CLOV
CLOV
FA
FA
Q4 25
1.61×
Q3 25
1.64×
Q2 25
1.65×
Q1 25
1.69×
Q4 24
1.66×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
FA
FA
Operating Cash FlowLast quarter
$-66.9M
$65.9M
Free Cash FlowOCF − Capex
$-69.0M
$62.2M
FCF MarginFCF / Revenue
-14.1%
14.8%
Capex IntensityCapex / Revenue
0.4%
0.9%
Cash ConversionOCF / Net Profit
19.01×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$188.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
FA
FA
Q4 25
$-66.9M
$65.9M
Q3 25
$12.1M
$72.4M
Q2 25
$5.4M
$37.3M
Q1 25
$-16.3M
$19.5M
Q4 24
$34.8M
$-85.7M
Q3 24
$50.0M
$43.5M
Q2 24
$44.8M
$32.0M
Q1 24
$25.9M
$38.3M
Free Cash Flow
CLOV
CLOV
FA
FA
Q4 25
$-69.0M
$62.2M
Q3 25
$11.4M
$71.2M
Q2 25
$4.8M
$36.1M
Q1 25
$-16.5M
$19.0M
Q4 24
$33.3M
$-86.0M
Q3 24
$49.6M
$43.1M
Q2 24
$44.4M
$31.4M
Q1 24
$25.5M
$38.0M
FCF Margin
CLOV
CLOV
FA
FA
Q4 25
-14.1%
14.8%
Q3 25
2.3%
17.4%
Q2 25
1.0%
9.2%
Q1 25
-3.6%
5.4%
Q4 24
9.9%
-28.0%
Q3 24
15.0%
21.6%
Q2 24
12.5%
17.0%
Q1 24
7.3%
22.4%
Capex Intensity
CLOV
CLOV
FA
FA
Q4 25
0.4%
0.9%
Q3 25
0.1%
0.3%
Q2 25
0.1%
0.3%
Q1 25
0.0%
0.1%
Q4 24
0.5%
0.1%
Q3 24
0.1%
0.2%
Q2 24
0.1%
0.4%
Q1 24
0.1%
0.2%
Cash Conversion
CLOV
CLOV
FA
FA
Q4 25
19.01×
Q3 25
27.91×
Q2 25
121.25×
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
17.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

FA
FA

First Advantage Americas$209.9M50%
Sterling$185.9M44%
First Advantage International$24.2M6%

Related Comparisons